Skip to content
value.today

Bluejay Diagnostics, Inc.

🇺🇸 Acton, Massachusetts, USAHealth CareFounded 2015
Total raised
$4 M
3 rounds on record
Latest round
$1 M
Oct 2020
First round on record
Mar 2017
Today
Went public
See the company page

Bluejay Diagnostics, Inc. is listed today as Bluejay Diagnostics, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bluejay Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2020$1 MNo. 3Under $2 million

Bluejay Diagnostics, Inc.: Raise no. 3, Oct 2020

Investors in this round

1 investor had bought by the notice of Jun 29, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Indranil Dey · Executive Officer, Director
  • Svetlana Dey · Executive Officer, Director · President
  • Donald Chase · Director
  • Douglas Wurth · Director
  • Mirza Medhi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Svetlana Dey, President. Source: SEC Form D, newest notice filed Jun 29, 2021. Read the notice at the SEC.

equitySEC
Apr 2019$2 MNo. 2Under $2 million

Bluejay Diagnostics, Inc.: Raise no. 2, Apr 2019

Investors in this round

6 investors had bought by the notice of Apr 23, 2019: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amman Haidri · Executive Officer · VP, President & Business Development
  • Indranil Dey · Executive Officer, Director · Chief Executive Officer
  • Svetlana Dey · Executive Officer, Director · President and Executive Director
  • Arthur Loomis · Director
  • Donald Chase · Director
  • Douglas Wurth · Director
  • Mirza Medhi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Svetlana Dey, President. Source: SEC Form D, newest notice filed Apr 23, 2019. Read the notice at the SEC.

equity, optionsSEC
Mar 2017$2 MNo. 1Under $2 million

Bluejay Diagnostics, Inc.: Raise no. 1, Mar 2017

Investors in this round

9 investors had bought by the notice of Apr 19, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$20,000
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$136,600
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Svetlana Dey · Executive Officer, Director
  • Arthur Loomis · Director
  • Donald Chase · Director
  • Douglas Wurth · Director
  • Indranil Dey · Director
  • Mirza Mehdi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Northeast Capital (CRD 32117) · Latham, New YorkSold in MA, MO, NY

Signed by Svetlana Dey, President. Source: SEC Form D, newest notice filed Apr 19, 2017. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bluejay Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2021).

    SEC Form D · Jun 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2021

That is all the official record says: Bluejay Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Bluejay Diagnostics, Inc. are on record.

Investors#

No investor of Bluejay Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 9 investors.

Largest shareholders today

Institutions holding Bluejay Diagnostics, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bluejay Diagnostics, Inc.
NameRoleNamed in
Indranil DeyExecutive officerJun 2021
Svetlana DeyPresidentJun 2021
Amman HaidriVP, President & Business DevelopmentApr 2019
Donald ChaseDirectorJun 2021
Douglas WurthDirectorJun 2021
Indranil DeyDirectorJun 2021
Mirza MedhiDirectorJun 2021
Svetlana DeyPresidentJun 2021
Arthur LoomisDirectorApr 2019
Mirza MehdiDirectorApr 2017

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.